Literature DB >> 26303495

Augmented 5-HT Secretion in Pulmonary Neuroepithelial Bodies from PHD1 Null Mice.

Simon Livermore1, Jie Pan, Herman Yeger, Peter Ratcliffe, Tammie Bishop, Ernest Cutz.   

Abstract

Sustained exposure to low oxygen concentration leads to profound changes in gene expression to restore oxygen homeostasis. Hypoxia-inducible factors (HIFs) comprise a group of transcription factors which accumulate under hypoxia and contribute to the complex changes in gene expression. Under normoxic conditions HIFs are degraded by prolyl-hydroxylases (PHD), however during hypoxia this degradation is inhibited causing HIF accumulation and subsequent changes in gene expression. Pulmonary neuroepithelial bodies (NEB) are innervated serotonin (5-HT)-producing cells distributed throughout the airway epithelium. These putative O(2) sensors are hypothesized to contribute to the ventilatory response to hypoxia. NEB dysfunction has been implicated in several paediatric lung diseases including neuroendocrine cell hyperplasia of infancy and sudden infant death syndrome, both characterized by a marked NEB hyperplasia with unknown functional significance. We have previously reported striking NEB hyperplasia in PHD1(-/-) mice making these mice a potential model to study the role of NEBs in paediatric lung diseases. Here we report in vitro studies on 5-HT release from NEB using this model.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26303495     DOI: 10.1007/978-3-319-18440-1_35

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  4 in total

Review 1.  Combination therapy in combating cancer.

Authors:  Reza Bayat Mokhtari; Tina S Homayouni; Narges Baluch; Evgeniya Morgatskaya; Sushil Kumar; Bikul Das; Herman Yeger
Journal:  Oncotarget       Date:  2017-06-06

Review 2.  HIF Oxygen Sensing Pathways in Lung Biology.

Authors:  Andrés A Urrutia; Julián Aragonés
Journal:  Biomedicines       Date:  2018-06-06

3.  Perinatal Hypoxemia and Oxygen Sensing.

Authors:  Gary C Mouradian; Satyan Lakshminrusimha; Girija G Konduri
Journal:  Compr Physiol       Date:  2021-04-01       Impact factor: 9.090

4.  Next-generation multimodality of nutrigenomic cancer therapy: sulforaphane in combination with acetazolamide actively target bronchial carcinoid cancer in disabling the PI3K/Akt/mTOR survival pathway and inducing apoptosis.

Authors:  Reza Bayat Mokhtari; Bessi Qorri; Narges Baluch; Angelo Sparaneo; Federico Pio Fabrizio; Lucia Anna Muscarella; Albina Tyker; Sushil Kumar; Hai-Ling Margaret Cheng; Myron R Szewczuk; Bikul Das; Herman Yeger
Journal:  Oncotarget       Date:  2021-07-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.